IL-10 is an anti-inflammatory myokine that positively modulates glucose metabolism [13], and to our knowledge, this is the first exploration of its regulation at the mRNA level in myotubes from patients with obesity with or without T2D accounting for the ability of patients with T2D to respond to exercise training. This evidence concerns the gene IL10 and obesity due to melanocortin 4 receptor deficiency.